SCR-LIP-000741 · Claim · machine-readable JSON →
Lymphatic abnormalities on lymphoscintigraphy are common in lipedema, limiting its specificity for distinguishing lipedema from lymphedema.
General proposition consolidated from 4 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 4 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (4)
- Hallazgos linfogammagráficos en pacientes con lipedema — Forner-Cordero et al. (2018) ✓ verified — consistent · cohort · 2018 · reading confidence: high
“Embora a linfocintilografia tenha sido usada para diferenciar lipedema de linfedema, foram encontradas alterações frequentes da função linfática em pacientes com lipedema; a presença de achados linfocintilográficos não descarta o diagnóstico de lipedema”
In 83 women with clinical lipedema, 47% had lymphatic alterations (mostly low grade, none severe), unrelated to stage, type, BMI or Stemmer sign; abnormal findings do not exclude lipedema.
The article directly evaluates lymphoscintigraphy in lipedema patients and addresses its diagnostic value for differentiating lipedema from lymphedema, but refines the question by showing lymphatic alterations are frequent in lipedema, limi - Lymphoscintigraphic alterations in lower limbs in women with lipedema in comparison to women with overweight/obesity — Chachaj et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
“Score linfocintilográfico médio: 1,686 ± 1,304 (lipedema) vs 2,323 ± 1,222 (obesidade) — sem diferença estatística (p=NS)”
Lymphoscintigraphy did not differentiate lipedema from leg-volume-matched overweight/obesity: abnormal scans 83% vs 96.8%, dermal backflow 5.9% vs 9.7%, mean score 1.686 vs 2.323 (NS).
Cross-sectional comparison directly tests whether lymphoscintigraphy can differentiate lipedema from obesity; finds no significant differences in any scintigraphic parameter, contradicting the diagnostic differentiation hypothesis for this - Assessment Modalities for Lower Extremity Edema, Lymphedema, and Lipedema: A Scoping Review — Markarian et al. (2024) ✓ verified — consistent · review · 2024 · reading confidence: high
“Valores de corte de US para diagnóstico de lipedema: espessura dérmica de 8,4 mm (região lateral da perna), 11,7 mm (pré-tibial) e 17,9 mm (coxa) — valores reportados por estudo de 2021; lipedema associado a aumento de espessura de pele e hipoecogenicidade subcutânea”
Scoping review concludes lymphoscintigraphy could not distinguish lipedema from lymphedema since lymphatic changes occur in both, whereas MRI/MRL and CT discriminated better.
Scoping review directly comparing MRI/MRL, lymphoscintigraphy, CT and other modalities for differentiating lipedema from lymphedema, reporting sensitivity/specificity and distinguishing features. - Enhancing lymphoscintigraphic specificity of lymphoedema diagnosis in patients with lipoedema (2025) ✓ verified — refining · cross sectional · 2025 · reading confidence: high
“Using lymphoscintigraphy to diagnose lymphoedema in patients with lipoedema resulted in low specificity (38.3%). By adjusting the interpretation criteria of the lymphoscintigraphic anomalies, we could achieve a specificity of 80.85%”
In 188 limbs of 94 women, standard criteria diagnosed lymphedema in lipedema with 38.3% specificity; modified interpretation raised specificity to 80.85% at reduced sensitivity.
The article shows standard lymphoscintigraphy has poor specificity (38.3%) and overdiagnoses lymphedema in lipedema patients, meaning it does not reliably differentiate the two unless interpretation criteria are modified, which still trades
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000030